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he global importance of breast cancer 
Tcannot be overest imated.  I t  is  the commonest female malignancy in the 
world. Breast cancer accounted for over 600,000 
deaths in women in 2018 making it the leading 
cause of deaths attributable to cancer among 
1
women globally.  Breast cancer is of similar 
importance in Nigeria. There were close to 30,000 
cases in 2018 resulting in an age standardized 
1 
incidence rate of 41.7/100000. Close to half of the 
incidences of breast cancers in Nigeria result in 
mortalities, as breast cancer is estimated to be 
responsible for 11564 deaths in 2018 with an age 
1
standardized mortality rate of 18.8/100000.  
Due to the importance of breast cancer both in 
Nigeria and globally, efforts to reduce its disease 
burden are imperative. These efforts need to be 
directed not only to treat and cure the disease in 
patients diagnosed with breast cancer, but also to 
prevent breast cancer in Nigerians who do not 
have it. This can be achieved by screening the at-
risk populations and identifying modiable risk 
factors.
One related group of modiable risk factors which 
are yet to be fully understood include diet rich in 
red meat, processed meat and fat; low physical 
activity (sedentary lifestyle) and anthropometric 
indices such as weight, height, body mass index 
(BMI), waist circumference, hip circumference and 
waist-to-hip ratio (WHR). In the Cancer 
Prevention Study II cohort, it was found that 
women with a higher BMI had a higher risk of 
2
dying from breast cancer.  In a pooled analysis of 
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prospective studies, the risk of breast cancer was 
found to be 30% higher in postmenopausal women 
with a BMI over 31kg/m2 compared with women 
3
with a BMI of 20kg/m2 or less.  Conversely, studies 
show that in premenopausal women elevated BMI 
and indices of adiposity are associated with a 
–46
reduced risk of breast cancer.  
Studies have showed that the relationship between 
BMI (anthropometry) and breast cancer is complex 
as, in addition to menopausal status, the 
association varies by race, age, and possibly 
7hormone receptor status.  Anthropometric indices 
are surrogates for body fatness as such the impact 
8
of body fat might not be well characterised.  For 
instance, weight (the numerator in BMI) does not 
9differentiate between lean mass and fat mass.  Also 
waist circumference and waist-hip-ratio (WHR) 
9
are indirect measures of central adiposity.  
Given these limitations of anthropometry in 
association with breast cancer, a more accurate 
assessment of the relationship between adiposity 
and breast cancer may be to directly measure body 
fat. Percentage body fat can be derived through 
10skin fold thickness (SFT).  Other methods to 
determine percent body fat include the bioelectric 
impedance assay (BIA) and dual energy x-ray 
absorptiometry (DEXA).
This study was thus undertaken to investigate the 
effect of adiposity on breast cancer risk among 
patients in the University College Hospital Ibadan 
by measuring percentage body fat through the SFT 
and BIA techniques.
MATERIALS AND METHODS
The study was conducted at the University College 
Hospital (UCH) Ibadan. The case group comprised 
of 70 patients with newly diagnosed breast cancer 
recruited at the Radiation Oncology and Surgical 
Oncology clinics, UCH between August 2016 and 
January 2017. The control group consisted of 71 
age-matched non-breast cancer patients recruited 
at the Family Medicine Clinic and Chief Tony 
Anenih Geriatric Centre Outpatient Clinic, UCH 
between February 2017 and May 2017.
For  cases ,  the  inclusion cr i ter ia  were  a 
histologically diagnosed patient with invasive 
breast cancer and those who had not had previous 
cancer treatment (mastectomy, chemotherapy, 
radiation therapy, hormonal therapy). The 
exclusion criteria  for cases were: Patients with  
uncontrolled chronic comorbidities such as 
h y p e r t e n s i o n  a n d  d i a b e t e s  m e l l i t u s , 
hypo/hyperthyroidism; patients on drugs known 
to affect lipid metabolism (HMG CoA reductase 
inhibitors (statins), Bile acid sequestrants, 
Nicotinic acid, Fibric acids, hormone replacement 
therapy and other hormonal agents); patients with 
poor performance status (ECOG ≥ 3); and patients 
with obvious nutritional impairment (severe 
mucositis, naso-gastric tube feeding, or parenteral 
feeding). The inclusion criterion for controls was 
the patient's gender and age (±1year) matches a 
case. The exclusion criteria applied to controls 
were: Patients with breast disease; patients with 
uncontrolled chronic comorbidities such as 
h y p e r t e n s i o n  a n d  d i a b e t e s  m e l l i t u s , 
hypo/hyperthyroidism, patients on drugs known 
to affect lipid metabolism (HMG CoA reductase 
inhibitors (statins), Bile acid sequestrants, 
Nicotinic acid, Fibric acids, hormone replacement 
therapy and other hormonal agents), patients with 
poor performance status (ECOG ≥ 3), patients with 
obvious nutritional impairment (severe mucositis, 
naso-gastric tube feeding, or parenteral feeding).
The study was (cross-sectional) case-control in 
design. Height, weight, BMI, estimated percentage 
body fat estimated from SFT's at four anatomical 
sites (triceps, biceps, subscapular, and suprailiac 
regions) according to Durnin and Womersley 
formula, and percentage body fat by BIA were 
measured in the cases and controls.
A questionnaire was used to retrieve information 
including sociodemographic data, clinical data 
and the above listed measures. Weight was 
measured to the nearest 0.1Kg and height to the 
nearest 0.1cm and from these values BMI was 
derived as weight divided by height squared 
2expressed as Kg/m .  Skinfold thickness was 
measured at 4 anatomical sites: the biceps, triceps, 
subscapular and suprailiac skinfold thicknesses 
using a calliper (Lange Skinfold Calliper). For each 
skin fold thickness, the average value of three 
readings was used. An indirect estimate of the 
percentage body fat calculated from the sum of the 
four skinfold thicknesses was derived using the 
formula proposed by Durnin and Womersley. The 
percentage body fat was also estimated through 
the Bioelectrical impedance assay method (BIA) 
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using the Omron Fat Loss Monitor (HBF-306, 
Omron Corporation). The study was approved by 
the joint ethical review committee of the University 
of Ibadan/University College Hospital, Ibadan 
(approval number: UI/EC/15/0460).
Statistical analysis
The IBM SPSS v21 was used to analyse the data. 
Descriptive statistics (means and standard 
deviation for quantitative variables and 
frequencies and percentages for qualitative) were 
presented and appropriate tables and charts were 
used. The t-test was used to compare the mean 
levels of the quantitative outcomes between cases 
and controls. 
Multiple logistic regression analysis was done on 
the signicant variables to further adjust for 
confounding variables in the comparison of 
outcomes between cases and controls. Level of 
signicance was set at 5%.
RESULTS
All the cases were women, their ages ranged from 
23 to 82 years with a mean age of 52.1±12.0 years. 
While the age rage and mean age of the age-
matched apparently healthy controls was 24 to 83 
years and 52.5±12.6 years respectively. There was 
no signicant difference between the cases and 
controls with regards to ethnicity, marital status, 
religion, education and occupation. However, over 
83% of the controls were employed as opposed to 
68.6% of cases, this difference was statistically 
signicant (P = 0.047) (table 1).
Table 1: Cross tabulation of Demographic parameters with disease status of study population 
Variable Disease Status P Value 
Case Control 
 N %` N %  
Marital status (N) 70  71  0.126 








































      





























































































































      
^ statistically signicant at 0.05
 
** Others include: Peace Corps ofcer, Librarian, Farmer and House-wife
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There were more cases who attained menarche at an early age and menopause and a later age. But these 
differences were not statistically signicant. In addition, a non-signicant higher proportion of cases 
breastfed for a shorter duration compared to controls (table 2).
Table 2: Reproductive factors associated with the disease status of study population  
Variable  Disease status  P Value  
Case  Control  



























































































































































      
* Fisher’s exact value reported
 
The difference between the cases and controls with regards to family history of breast cancer and 
presence or absence of comorbidities was not statistically signicant. The proportion of cases that were 
either currently taking alcohol or had taken in the past (14.5%) was higher than that of the controls 
(5.6%). However, this difference was not statistically signicant. None of the cases nor controls had a 
history of smoking. The cases had signicantly higher systolic and diastolic blood pressures compared 
to the controls (table 3).
Table 3: Medical and social factors associated with disease status of the study population
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The cases had statistically signicantly lower 
weights than the controls (P = 0.002). This was also 
the relationship among the postmenopausal 
women among whom the mean weight was 66.7Kg 
compared to 77.1Kg in the controls (P = 0.003). The 
premenopausal cases also had a lower mean 
weight compared to the controls. However, the 
difference was not statistically signicant (P = 
0.160) (table 4). The average height in the two 
groups was the same. Therefore, the cases had a 
lower mean BMI compared to controls (P = 0.001). 
There was no signicant difference in the BMI 
among the premenopausal women, even though 
the premenopausal cases had lower BMIs 
compared to the controls. The postmenopausal 
2
cases also had lower mean BMIs (25.0Kg/m ) 
c o m p a r e d  t o  p o s t m e n o p a u s a l  c o n t r o l s 
2
(29.5Kg/m ), this difference was statistically 
signicant (P = 0.05) (table 4). The cases had 
signicantly lower triceps SFTs among all the 
participants and among the postmenopausal 
women. Similarly, the cases had signicantly 
lower biceps SFTs this was reected in all the 
participants and in both the postmenopausal and 
premenopausal subdivisions. The cases also had 
signicantly lower subscapular SFTs but this was 
only seen when all the participants were 
compared. However, the difference in suprailiac 
SFTs between the cases and controls was not 
statistically signicant. The estimated percentage 
body fat by SFTs was signicantly lower in the 
cases when comparing all participants and in the 
postmenopausal women. The percentage body fat 
by BIA was lower in the cases among all 
participants and both the postmenopausal and 
premenopausal subdivisions. However, the 
differences were not statistically signicant.
Table 4: Comparing mean values of anthropometric indices in cases and controls
Variable Menopausal 
status  
Case  Control  P  
 N  ±SD  N   ±SD   
Weight (Kg)  Premenopausal  28  68.2±17.0  37  74.9±20.0  0.160  
 Postmenopausal  42  66.7±14.8  34  77.1±13.9  0.003^  
 Both  70  67.3±15.6  71  76.0±17.3  0.002^  
Height (m)  Premenopausal  28  1.6±0.1  37  1.6±0.1  0.309  
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N 136 136  136  136  136  134  
BMI Pearson 
Correlation 




















































































P Value .030 .001 .032 .000 .000
















* Correlation is signicant at the 0.05 level
 
Table 5 shows the results of Pearson correlation analysis of the statistically signicant variables on 
bivariate analysis (employment status, systolic BP, diastolic BP, BMI, percentage body fat by SFT), 
though percentage body fat by BIA was not statistically signicant on t test, we also included it in the 
correlation analysis. Employment status was not moderately or strongly correlated with any of the 
above factors. Systolic BP was not moderately or strongly correlated to any of the factors in the analysis 
except diastolic BP, this was the same picture in diastolic BP. BMI was strongly correlated to percentage 
body fat measured both by SFT and BIA, with Pearson correlation values of 0.751 and 0.717 respectively 
(P value < 0.001). However, percentage body fat by SFT was only moderately correlated to percentage 
body fat by BIA, with a Pearson correlation value of 0.651 (P value < 0.001).
 



















Condence level of OR
 













         Employed
  
1.000
    
1.000







































0.762 1.203 0.363 3.985
Systolic BP









0.028^ 1.021 1.002 1.041
% body fat 
SFT
0.005^ 0.921 0.870 0.975
Model ? 2
 















** Correlation is signicant at the 0.01 level
^ statistically signicant at 0.05
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Table 6 shows stepwise logistic regression models 
used to analyse the risk/association of non-
correlating variables which were hitherto 
signicant on bivariate analysis (employment 
status, systolic blood pressure, and percent body 
fat SFT). This was to conrm the independence of 
the association between percentage body fat and 
breast cancer. Though diastolic blood pressure was 
statistically signicant with t test, we did not 
include it in the logistic regression models as it 
strongly correlated with systolic blood pressure in 
the correlation analysis (table 5). Percentage body 
fat by BIA was not statistically signicant on t test, 
it was thus not used in the logistic regression 
model, rather we used percentage body fat by SFT. 
In addition, since percentage body fat and BMI 
were strongly correlated, we did not include BMI 
in the logistic regression models. Model 3 indicates 
that elevated systolic blood pressure was an 
independent associated factor for breast cancer (P 
= 0.028). With an odds ratio (OR) of 1.021, every 
1mmHg increase in systolic blood pressure, 
increases the likelihood of breast cancer by 2.1%. 
Low percentage body fat SFT was independently 
associated with breast cancer (P = 0.005). The OR of 
0.921 indicates every 1% increase in percentage 
body fat, as measured by skin fold thickness, 
reduced the likelihood of breast cancer by 7.9%. 
The model also hinted at the fact that the 
association between unemployment and breast 
cancer was confounded by low percentage body fat 
SFT, as it lost its statistical signicance in the 
model.
DISCUSSION
This study was embarked on to observe the 
correlation of adiposity with breast cancer. The 
mean age (52.1±12.0 years) of the study sample 
indicates breast cancer continues to be a disease of 
the middle aged and elderly. The study also 
illustrated the negative impact a diagnosis of 
cancer has on one's capacity to get employed and or 
to remain employed. A study by Park et al noted 
that cancer patients in Korea were more likely to 
lose their jobs and less likely to get re-employed 
compared to those who are not aficted with the 
11 disease.  However, it is needful to investigate the 
true picture of the association between breast 
cancer and unemployment. As further analysis in 
our study showed unemployment did not remain 
an independent risk factor upon logistic regression 
indicating that there are other factors that may be 
relevant confounders.
The mean systolic and diastolic blood pressure 
values were found to be statistically signicantly 
higher among the cases than the controls. This may 
be due to the anxieties associated with a new 
diagnosis of breast cancer. However, these mean 
blood pressure values, though higher than the 
mean value of the controls, were still within the 
normal limits.
Studies showed a higher incidence of breast cancer 
among those with a daily consumption of four or 
12more alcoholic drinks per day.  In this study, 
quantity of alcohol consumed daily was not 
recorded as the values are difcult to estimate with 
certainty in this cohort of patients. However, cases 
had more proportions of women who had taken 
alcohol in the past or current alcohol users, though 
the association was not signicant.
The mean height among the cases and controls in 
t h i s  s t u d y  s a m p l e  w a s  s i m i l a r  i n  b o t h 
postmenopausal and premenopausal women. 
However, previous studies by Adebamowo et al 
and Ogundiran et al revealed taller women were at 
13,14 
increased risk for breast cancer. It is not clear 
why our study did not follow this trend.
This study revealed a statistically signicant 
higher weight in controls compared to cases. 
Factoring in the constant mean height in the entire 
study population,  one would expect the 
signicantly higher BMI of the controls in this 
study. This pattern is particularly signicant 
among the postmenopausal women in this study 
(P value = 0.001). Among the premenopausal 
women, there was also a higher mean BMI in the 
controls compared to the cases of breast cancer. 
However, this was not signicant (P value = 0.102). 
Cases with low BMI compared to controls is not in 
keeping with ndings in global literature, except in 
premenopausal breast cancer. This is due to 
anovulatory menstrual cycles associated with 
premenopausal obesity which result in low serum 
15,16
oestrogen levels.  However, previous studies in 
our environment, particularly the studies done in 
our centre differ from global ndings. The study by 
Adebamowo et  al  showed no signicant 
13 association, while the study by Ogundiran et al 
revealed an inverse association between BMI and 
breast cancer indicating low BMI to be associated 
14
with breast cancer (P-trend 0.009).  This was 
similar to the nding in this study.
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The anovulatory menstrual cycle effect noted in the 
global association between low BMI and 
premenopausal breast cancer can not explain the 
results this study noted. For one, the inverse 
association between BMI and breast cancer among 
the premenopausal women in this study was not 
signicant. Furthermore, this inverse association 
between BMI and breast cancer persisted 
signicantly among postmenopausal women in 
our study. If it were the anovulatory theory that 
was responsible for the premenopausal inverse 
risk, the association in the postmenopausal women 
should have ipped into a direct risk as seen 
among postmenopausal women in global studies.
This study noted a lower mean percentage body fat 
among the breast cancer cases compared to the 
controls in spite of the method of assessment. 
However, the difference was only signicant using 
the skin fold thickness (SFT) method. This same 
pattern was seen in the postmenopausal women. 
However,  in the premenopausal women, 
percentage body fat was lower in the cases by both 
techniques but none was signicant. This study, 
contrary to previous studies inversely associates 
percentage body fat with breast cancer with an OR 
0.921 (95% CI 0.870-0.975). A study conducted in 
Brazil by Martins et al also utilised skin fold 
thickness and bioelectric impedance assay (BIA) to 
compare percentage body fat between cases of 
breast cancer and controls. That study noted 
percentage body fat was higher in cases than 
controls, though only signicantly higher with the 
17BIA technique.
 Similarly another case-control study in Uruguay 
noted a signicantly higher percentage body fat by 
18 
SFT in the cases of breast cancer. However, in a 
similar case control study done among African 
Americans, there was no statistically signicant 
difference between the women with breast cancer 
19
and the controls.  The trends noted by these 
comparative cross sectional case control studies 
(excluding the one done among African 
Americans) were corroborated by longitudinal 
and prospective cohort studies. For instance, the 
longitudinal study utilizing data from the 
Women's Health Initiative (WHI). On follow up, 
incident cases of breast cancer were recorded and 
they were found more in women with higher 
percentage body fat. The hazard ratio of highest 
quintile to lowest quintile was 1.5; CI 1.33-1.99 
9 
(Ptrend = 0.007). The Swedish population based 
prospective cohort study by Borgquist et al 
reported an increased risk of breast cancer in 
women with the highest quintile of percentage 
body fat compared to the lowest RR 1.65 (95% CI 
1.12-2.43) Ptrend < 0.01.8 Another population 
based cohort by Krebs et al in the US with a follow 
up period of just over 11 years had similar ndings. 
The women who later had breast cancer had higher 
mean percentage body fat compared to the women 
who did not develop breast cancer during the 
20
follow up period.
Considering the fact that the study conducted 
among African Americans showed no signicant 
relationship between percentage body fat and 
breast cancer; ethnicity may explain the reason 
why this study showed a relationship which is in 
contrast to many previous ndings. However, 
ethnicity is unlikely to be the sole reason for the 
ndings in this study. This is because the OR's in 
the African American study were only <1 (similar 
to this study) among premenopausal women. In 
postmenopausal women the OR's were >1 
indicating percentage body fat was a risk for breast 
cancer, though, as their 95% condence intervals 
included the null value, they were also not 
19
signicant.  
The Pearson correlation analysis done showed that 
BMI was strongly correlated to percentage body fat 
by SFTs and percentage body fat by BIA. In 
addition, the same correlational analysis revealed 
percentage body fat by SFT and percentage body 
fat BIA were only moderately correlated. This 
study then proves BMI to be as good a surrogate for 
adiposity as percentage body fat by SFT which is 
the acceptable technique for epidemiological 
21,22
studies on percentage body fat.  The reading of 
percentage body fat measured by the BIA 
technique are highly dependent on the hydration 
status of the participant and when the participant 
23,24 
took a meal.
As such for adequate and consistent readings, strict 
protocols regarding the time of the day the 
measurement is taken and the amount of water and 
meals taken before the procedure are followed. 
Such strict protocols were not followed in this study, 
as it would be difcult to do so among the patients we 
recruited at their respective outpatient clinics. This 
could be the reason why percentage body fat BIA was 
not statistically signicant and why it was only 
moderately correlated to percentage body fat SFT.
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As such, the same explanation for the inverse 
association of BMI with breast cancer could also 
pertain to the inverse association between 
percentage body fat SFT and breast cancer. This 
implies, the advanced presentation, lower 
socioeconomic status (unemployment) and 
possibly poorer nutrition in the cases of breast 
cancer recruited might be an additional reason for 
the pattern seen.
The key to this inverse association would be an 
explanation peculiar to our environment. Adding 
up the sociodemographic and clinicopathologic 
presentations indicate the cases of breast cancer 
were more likely to be unemployed, and would 
more likely present in advanced stages with higher 
grades of  differentiat ion.  Hence,  in our 
environment, breast cancer patients present at 
stages in which the wasting effect of breast cancer 
has set in or is already in play. Additionally, the 
socioeconomic status of patients with breast cancer 
i s  re lat ively  lower ,  as  they are  usual ly 
unemployed. In Nigeria, the ratio of oncological 
centres with radiotherapy machines to citizen is 
25abysmally low, (9 centres to 203,452,505 citizen ). 
Patients thus need to travel from distant regions of 
the country to seek oncological care. The living 
conditions of most of the patients that travel from 
distant regions are usually suboptimal. Hence, the 
nutritional status of cases of breast cancer 
compared to population controls or apparently 
healthy hospital controls, who usually reside 
within the city where the studies are done, would 
be unfavourable.
CONCLUSION
The study indicated newly diagnosed patients 
with breast cancer in UCH, Ibadan have 
signicantly higher blood pressures, and were 
likely to be unemployed compared to age matched 
apparently healthy controls.
The study also showed the breast cancer patients 
had lower weights, BMI and percentage body fat as 
measured by skin fold thicknesses compared to the 
controls and these differences were satistically 
signicant. On logistic regression, low percentage 
body fat was proven to be an independent 
associated factor with breast cancer.
LIMITATIONS
This study was cross-sectional by design. The 
ndings noted were those seen in the participants 
of the study on the day they were recruited. The 
relationship between the factors studied are thus 
limited to associations and not cause-effect or risk 
factors.
The controls used were apparently healthy 
patients of the family medicine department and 
Chief Tony Anenih Geriatric Centre clinics. It was 
ascertained that the controls recruited had no 
clinical evidence of breast cancer or complaints of 
a n y  o t h e r  b r e a s t  p a t h o l o g y .  H o w e v e r , 
mammography studies were not done in them. 
This implies a remote possibility of a control 
having a yet to be discovered early breast cancer.
RECOMMENDATIONS
The inverse relationship between adiposity (BMI 
and percentage body fat) and breast cancer in our 
environment needs to be further investigated. This 
requires larger, better funded and more carefully 
conducted studies. This would be helpful to 
analyse by categories such as group staging, T-
stage and other cut-off points such as those for 
26percentage body fat proposed by Gallagher et al.  
BMI was strongly correlated to percentage body fat 
by SFT and it is more easily determined by 
measuring weight and height compared to 
measuring skinfold thicknesses at varying 
anatomical sites. We thus recommend its 
continued use epidemiologically and for personal 
purposes at community level to measure and track 
adiposity. We do not recommend the use of 
percentage body fat by BIA for research purposes 
except if strict protocols regarding hydration and 
23,24
meals of the participants are followed.  On the 
other hand, this study adds more credence to the 
fact that measuring percentage body fat by the skin 
fold thickness technique is adequate for 
21
epidemiological intent.  The DEXA technique is 
22the gold standard.  It is however expensive and 
capital intensive. Also, it is not feasible to 
frequently track adiposity over a period of time. It 
is not advisable to expose a person to x-rays weekly 
or monthly.
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